Dr. Mike Graham Named Head of R&D at Bayer Crop Science
Dr. Mike Graham Named Head of R&D at Bayer Crop Science Bayer has officially announced that Dr. Mike Graham will assume the role of Head of Research & Development (R&D)…
Read MoreDr. Mike Graham Named Head of R&D at Bayer Crop Science
Quince Therapeutics Shares Business Update & 2024 Financial Results
Quince Therapeutics Shares Business Update & 2024 Financial Results Quince Therapeutics, Inc., a late-stage biotechnology company focused on leveraging a patient’s own biology to treat rare diseases, has provided an…
CEL-SCI: Multikine Boosts Quality of Life by Up to 95% in Head & Neck Cancer Patients
CEL-SCI: Multikine Boosts Quality of Life by Up to 95% in Head & Neck Cancer Patients CEL-SCI Corporation (NYSE American: CVM) has recently announced the publication of new data from…
Neurogene Announces Q4 & Full-Year 2024 Results, Updates
Neurogene Announces Q4 & Full-Year 2024 Results, Updates Neurogene Inc., a clinical-stage company dedicated to developing life-changing genetic medicines for patients and families affected by rare neurological diseases, has announced…
IFF Pharma Showcases Next-Gen Excipients at CPHI Japan 2025
IFF Pharma Showcases Next-Gen Excipients at CPHI Japan 2025 IFF Pharma Solutions is set to showcase its latest cutting-edge excipient technologies at CPHI Japan 2025, reinforcing its commitment to revolutionizing…
Pearsanta Acquires Adductomics Tech for Early Cancer Detection
Pearsanta Acquires Adductomics Tech for Cancer Risk Monitoring Aditxt, Inc. (“Aditxt” or the “Company”), a social innovation platform accelerating promising health innovations, has announced that its subsidiary, Pearsanta, Inc. (“Pearsanta”),…
DNAnexus & AlidaBio Partner to Advance RNA Analysis
DNAnexus & AlidaBio Partner to Advance RNA Analysis DNAnexus, Inc., a leading provider of enterprise platforms for precision health data, has announced a strategic collaboration with Alida Biosciences (AlidaBio), a…
J&J Boosts U.S. Investment to $55B Over Four Years
J&J Boosts U.S. Investment to $55B Over Four Years Johnson & Johnson, one of the world’s leading healthcare and pharmaceutical companies, has announced a significant increase in its investment in…
Johnson & Johnson to Build Advanced Biologics Facility in North Carolina
Johnson & Johnson to Build Advanced Biologics Facility in North Carolina Johnson & Johnson (the “Company”) is set to break ground on a new, cutting-edge biologics manufacturing facility in Wilson,…
AstraZeneca to Invest $2.5B in Beijing R&D, Biotech & Manufacturing
AstraZeneca to Invest $2.5B in Beijing R&D, Biotech & Manufacturing AstraZeneca has announced a major investment of $2.5 billion in Beijing to establish its sixth global strategic R&D centre, alongside…
Novartis’ Fabhalta® (iptacopan) Wins Third FDA Approval for C3G
Novartis’ Fabhalta® (iptacopan) Wins Third FDA Approval for C3G Novartis has announced that the U.S. Food and Drug Administration (FDA) has approved oral Fabhalta® (iptacopan) for the treatment of adults…
Omeros Updates Phase 3 Zaltenibart PNH Trial
Omeros Updates Phase 3 Zaltenibart PNH Trial Omeros Corporation has announced that site activation for enrollment is underway in its Phase 3 clinical trial program evaluating zaltenibart (OMS906) for the…